AMEND news in Month: September 2023
Volunteer for a new research project
Genetic Counselling Student from Cardiff University, Emma Coats, would like to hear from patients with any of the MEN syndromes and who are based in the UK for her research study looking at patient experiences of surveillance (outpatient appointments, test, scans, etc).
AMEND Attends INCA Summit
AMEND is a member of the International Neuroendocrine Cancer Alliance (INCA), the organisation responsible for NET Cancer Day (AKA Neuroendocrine Cancer Day). Each year, INCA holds a Summit where their member organisations from around the world can get together and discuss projects, plans, strategy, and also share best practice ideas with one another.
NETS in RETS
November 10th each year is NET Cancer Day, initiated by the International Neuroendocrine Cancer Alliance, of which AMEND is a member representing genetic neuroendocrine tumour syndromes. To better explain the link between NETs and RETS (rare endocrine tumours and syndromes), join us for our webinar, NETs in RETS, with Professor Karim Meeran on Thursday 9th November from 18:00-19:00.